Login to Your Account

Amgen Buys Brazilian Drug Firm & Brazilian Drug Rights

By Anette Breindl

Monday, April 11, 2011
Thousand Oaks, Calif.- based biotech giant Amgen Inc. has taken several steps to expand its operations in Brazil: On Friday the company announced it acquired privately held Brazilian drugmaker Bergamo and reacquired the rights to several of its own products in Brazil.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription